FDA Class III Recall: TESTOSTERONE by Teva Pharmaceuticals USA, Inc — Recall Details

Key facts

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Teva Pharmaceuticals USA, Inc. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Teva Pharmaceuticals USA, Inc should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Teva Pharmaceuticals USA, Inc directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

What this classification means

A Class III recall is FDA’s least serious classification. FDA assigns Class III when use of, or exposure to, the recalled product is not likely to cause any adverse health consequences, but the product still violates FDA labeling or manufacturing regulations. Class III recalls are still tracked and reported to FDA, but typically receive lighter monitoring than Class I or II. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class III, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall.

Teva Pharmaceuticals USA, Inc’s FDA history

Argus HQ has recorded 41 total FDA actions tied to Teva Pharmaceuticals USA, Inc: 0 warning letters, 39 recalls, 2 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

Where can I verify this recall directly with FDA?

The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

Is Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, recalled?

Yes. FDA lists a Class III recall by Teva Pharmaceuticals USA, Inc for Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17., reported 20251210, with status "Ongoing." FDA recall number: D-0198-2026.

What is the recall class for Teva Pharmaceuticals USA, Inc's recall?

FDA classified this recall as Class III. A Class III recall is FDA’s least serious classification. FDA assigns Class III when use of, or exposure to, the recalled product is not likely to cause any adverse health consequences, but the product still violates FDA labeling or manufacturing regulations.

Why was Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, recalled?

FDA's recall record states the reason as: Defective Container - A defect in the side-seal which allows leakage of product.

Related enforcement actions

• Recall: Teva Pharmaceuticals USA, Inc — Class II recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20… →
• Recall: Teva Pharmaceuticals USA, Inc — Class II recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30… →
• Recall: Teva Pharmaceuticals USA, Inc — Class II recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10… →
• Recall: Teva Pharmaceuticals USA, Inc — Class II recall: Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx O… →
• Recall: Teva Pharmaceuticals USA, Inc — Class II recall: Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC:… →
• Recall: Teva Pharmaceuticals USA, Inc — Class II recall: Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bott… →
• Recall: Teva Pharmaceuticals USA, Inc — Class II recall: Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC:… →
• Recall: Teva Pharmaceuticals USA, Inc — Class II recall: Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg pe… →